Picture of Celltrion Healthcare Co logo

091990 — Celltrion Healthcare Co News Story

0.000.00%
kr flag iconLast trade - 00:00
HealthcareAdventurousLarge Cap

Brief: Celltrion USA Announces Submission Of The Biologics License Application (BLA) Of Novel Subcutaneous Formulation Of Ct-P13 To U.S. Food And Drug Administration

Dec 22 (Reuters) - Celltrion Healthcare Co Ltd
 091990.KQ :
    * CELLTRION USA ANNOUNCES SUBMISSION OF THE BIOLOGICS
LICENSE
APPLICATION (BLA) OF NOVEL SUBCUTANEOUS FORMULATION OF CT-P13 TO
U.S. FOOD AND DRUG ADMINISTRATION

Source text for Eikon:  ID:nBw4VY6l4a 
Further company coverage:  091990.KQ 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Celltrion Healthcare Co

See all news